Browse By: Country ι Category ι Tag
Home  »  Pancreatic Cancer

Pancreatic Cancer Market Research Reports

More

Pancreatic Cancer Global Clinical Trials Review, H1, 2017
Summary GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ differ
Published Date: Mar 2017
Published By: GlobalData

Price: $2500
China Pancreatic Cancer Pipelines Market Research Report 2017
Sales, means the sales volume of Pancreatic Cancer Pipelines Revenue, means the sales value of Pancreatic Cancer Pipelines This report studies Pancreatic Cancer Pipelines in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Birken Fibrocell Science GlaxoSmithKline InMed Pharmaceuticals Karus Therapeutics RegeneRex Biopharmaceuticals Scioderm Shire Stratatech Market Segment by Regions (provinces), covering South China East China Southwest China Northeast China North China Central China Northwest China Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Split by Application, this report focuses on consumption, mar
Published Date: Mar 2017
Published By: QYResearch

Price: $3200
Europe Pancreatic Cancer Pipelines Market Report 2017
Sales, means the sales volume of Pancreatic Cancer Pipelines Revenue, means the sales value of Pancreatic Cancer Pipelines This report studies sales (consumption) of Pancreatic Cancer Pipelines in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering Birken Fibrocell Science GlaxoSmithKline InMed Pharmaceuticals Karus Therapeutics RegeneRex Biopharmaceuticals Scioderm Shire Stratatech Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Pancreatic Cancer Pipelines in these countries, from 2011 to 2021 (forecast), like Germany France UK
Published Date: Feb 2017
Published By: QYResearch

Price: $3900
United States Pancreatic Cancer Pipelines Market Report 2017
Sales, means the sales volume of Pancreatic Cancer Pipelines Revenue, means the sales value of Pancreatic Cancer Pipelines This report studies sales (consumption) of Pancreatic Cancer Pipelines in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Birken Fibrocell Science GlaxoSmithKline InMed Pharmaceuticals Karus Therapeutics RegeneRex Biopharmaceuticals Scioderm Shire Stratatech Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Split by applications, this report focuses on sales, market share and growth rate of Pancreatic Cancer Pipelines in each application, can
Published Date: Feb 2017
Published By: QYResearch

Price: $3800
Global Pancreatic Cancer Pipelines Sales Market Report 2017
Sales, means the sales volume of Pancreatic Cancer Pipelines Revenue, means the sales value of Pancreatic Cancer Pipelines This report studies sales (consumption) of Pancreatic Cancer Pipelines in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Birken Fibrocell Science GlaxoSmithKline InMed Pharmaceuticals Karus Therapeutics RegeneRex Biopharmaceuticals Scioderm Shire Stratatech Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Pancreatic Cancer Pipelines in these regions, from 2011 to 2021 (forecast), like United States China Europe Japan
Published Date: Feb 2017
Published By: QYResearch

Price: $4000
Global PancreatIc Cancer PIpelInes Market Research Report 2017
ProductIon, means the output of PancreatIc Cancer PIpelInes Revenue, means the sales value of PancreatIc Cancer PIpelInes ThIs report studIes PancreatIc Cancer PIpelInes In Global market, especIally In North AmerIca, Europe, ChIna, Japan, Southeast AsIa and IndIa, focuses on top manufacturers In global market, wIth capacIty, productIon, prIce, revenue and market share for each manufacturer, coverIng BIrken FIbrocell ScIence GlaxoSmIthKlIne InMed PharmaceutIcals Karus TherapeutIcs RegeneRex BIopharmaceutIcals ScIoderm ShIre Stratatech Market Segment by RegIons, thIs report splIts Global Into several key RegIons, wIth productIon, consumptIon, revenue, market share and growth rate of PancreatIc Cancer PIpelInes In these regIons, from 2011 to 2021 (forecast), lIke North AmerIca Europe ChIna Ja
Published Date: Feb 2017
Published By: QYResearch

Price: $2900
Global Drugs for Metastatic Pancreatic Cancer Industry 2017, Trends and Forecast Report
The report firstly introduced the Drugs for Metastatic Pancreatic Cancer basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Drugs for Metastatic Pancreatic Cancer Market; 3.) the North American Drugs for Metastatic Pancreatic Cancer Market; 4.) the European Drugs for Metastatic Pancreatic Cancer Marke
Published Date: Feb 2017
Published By: 9Dimen Research

Price: $2850
Global Pancreatic Cancer Partnering 2010 to 2017
• Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation o
Published Date: Feb 2017
Published By: Current Partnering

Price: $1495
Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Metastatic Pancreatic Cancer Report is to understand the market and pipeline status of the drugs around the Metastatic Pancreatic Cancer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Pancreatic Cancer Report is to understand the market and pipeline status of the drugs around the Pancreatic Cancer to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Pancreatic Cancer. While the lea
Published Date: Jan 2017
Published By: DelveInsight

Price: $2000
Pancreatic Cancer - Epidemiology Forecast To 2023
Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication. Scope of the Report • The Report includes the prevalent population and how will it change over the next eight years. • Prevalent or incident cases segmented by age and sex. • Coverage of key Pancreatic Cancer subpopulations and its prevalent or incident cases • The key differences in epidemiology patterns across the seven market segments Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Pancreatic Cancer market. • Identifying prevalent patient populations as well as risk factors in the globa
Published Date: Jan 2017
Published By: DelveInsight

Price: $2750
Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2023
DelveInsight’s Pancreatic Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Pancreatic Cancer for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Pancreatic Cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Pancreatic Cancer till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Pancreatic Cancer market. • Identifying patient populations in the g
Published Date: Jan 2017
Published By: DelveInsight

Price: $4950
Global Pancreatic Cancer Industry 2016, Trends and Forecast Report
The report firstly introduced the Pancreatic Cancer basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Pancreatic Cancer industry; 3.) the North American Pancreatic Cancer industry; 4.) the European Pancreatic Cancer industry; 5.) market entry and investment feasibilit
Published Date: Dec 2016
Published By: 9Dimen Research

Price: $2850
Pancreatic Cancer - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pancrea
Published Date: Dec 2016
Published By: Global Markets Direct

Price: $2500
China Drugs for Metastatic Pancreatic Cancer Market Research Report 2016
Sales, means the sales volume of Drugs for Metastatic Pancreatic Cancer Revenue, means the sales value of Drugs for Metastatic Pancreatic Cancer This report studies Drugs for Metastatic Pancreatic Cancer in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering AbbVie Inc. Aduro BioTech, Inc. ArQule, Inc. Array BioPharma Inc. AstraZeneca Plc Axcentua Pharmaceuticals AB Berg LLC Bionomics Limited Boehringer Ingelheim GmbH Boston Biomedical, Inc. Bristol-Myers Squibb Company Celgene Corporation Clovis Oncology, Inc. Cornerstone Pharmaceuticals, Inc. CTI BioPharma Corp. CytRx Corporation Eleison Pharmaceuticals LLC Eli Lilly and Company Ensol Biosciences Inc. Erytech Pharma SA F. Hoffmann-La Roche Lt
Published Date: Dec 2016
Published By: QYResearch

Price: $3200
Europe Drugs for Metastatic Pancreatic Cancer Market Report 2016
Sales, means the sales volume of Drugs for Metastatic Pancreatic Cancer Revenue, means the sales value of Drugs for Metastatic Pancreatic Cancer This report studies sales (consumption) of Drugs for Metastatic Pancreatic Cancer in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering AbbVie Inc. Aduro BioTech, Inc. ArQule, Inc. Array BioPharma Inc. AstraZeneca Plc Axcentua Pharmaceuticals AB Berg LLC Bionomics Limited Boehringer Ingelheim GmbH Boston Biomedical, Inc. Bristol-Myers Squibb Company Celgene Corporation Clovis Oncology, Inc. Cornerstone Pharmaceuticals, Inc. CTI BioPharma Corp. CytRx Corporation Eleison Pharmaceuticals
Published Date: Dec 2016
Published By: QYResearch

Price: $3900
Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
Summary GlobalData's Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Pancreatic Cancer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer Diagnostic Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's tea
Published Date: Dec 2016
Published By: GlobalData

Price: $4000
United States Drugs for Metastatic Pancreatic Cancer Market Report 2016
Sales, means the sales volume of Drugs for Metastatic Pancreatic Cancer Revenue, means the sales value of Drugs for Metastatic Pancreatic Cancer This report studies sales (consumption) of Drugs for Metastatic Pancreatic Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering AbbVie Inc. Aduro BioTech, Inc. ArQule, Inc. Array BioPharma Inc. AstraZeneca Plc Axcentua Pharmaceuticals AB Berg LLC Bionomics Limited Boehringer Ingelheim GmbH Boston Biomedical, Inc. Bristol-Myers Squibb Company Celgene Corporation Clovis Oncology, Inc. Cornerstone Pharmaceuticals, Inc. CTI BioPharma Corp. CytRx Corporation Eleison Pharmaceuticals LLC Eli Lilly and Company Ensol Biosciences Inc. Erytech Pharma SA F. Hoffmann-La Roche Ltd. Fou
Published Date: Nov 2016
Published By: QYResearch

Price: $3800
Global Drugs for Metastatic Pancreatic Cancer Sales Market Report 2016
Sales, means the sales volume of Drugs for Metastatic Pancreatic Cancer Revenue, means the sales value of Drugs for Metastatic Pancreatic Cancer This report studies sales (consumption) of Drugs for Metastatic Pancreatic Cancer in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering AbbVie Inc. Aduro BioTech, Inc. ArQule, Inc. Array BioPharma Inc. AstraZeneca Plc Axcentua Pharmaceuticals AB Berg LLC Bionomics Limited Boehringer Ingelheim GmbH Boston Biomedical, Inc. Bristol-Myers Squibb Company Celgene Corporation Clovis Oncology, Inc. Cornerstone Pharmaceuticals, Inc. CTI BioPharma Corp. CytRx Corporation Eleison Pharmaceuticals LLC Eli Lill
Published Date: Nov 2016
Published By: QYResearch

Price: $4000
Global Drugs for Metastatic Pancreatic Cancer Market Professional Survey Report 2016
Production, means the output of Drugs for Metastatic Pancreatic Cancer Revenue, means the sales value of Drugs for Metastatic Pancreatic Cancer This report studies Drugs for Metastatic Pancreatic Cancer in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering AbbVie Inc. Aduro BioTech, Inc. ArQule, Inc. Array BioPharma Inc. AstraZeneca Plc Axcentua Pharmaceuticals AB Berg LLC Bionomics Limited Boehringer Ingelheim GmbH Boston Biomedical, Inc. Bristol-Myers Squibb Company Celgene Corporation Clovis Onc
Published Date: Nov 2016
Published By: QYResearch

Price: $3500

Back To Top